The Study about the awakening time in continuous intravenous midazolam

The Study about the awakening time in continuous intravenous midazolam - The Study about the awakening time in continuous intravenous midazolam

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000025556

Enrollment

Registered

2017-01-10

Start date

2017-01-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Caries, teeth loss

Interventions

continuous intravenous midazolam

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients of ASA1 or ASA2 scheduled for dental treatment at NDU hospital

Exclusion criteria

Exclusion criteria: 1. Patients commonly used psychotropic drugs, anti-psychotic drugs and sleeping pills 2. Obesity 3. Patients administered before surgery the sedative 4. Patients having history of drug allergy

Design outcomes

Primary

Measure	Time frame
return permission time	—

Countries

Japan

Contacts

Public ContactNaoko Murata

The Nippon Dental University, School of Life Dentistry at Tokyo Department of Dental Anesthesiology

nmurata.0210@gmail.com03-3261-6560

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026